UPDATE: Citigroup Raises PT on Cynosure Following 2Q13 Results Report
In a report published Thursday, Citigroup analyst Matthew J. Dodds reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target from $36.00 to $41.00.
In the report, Citigroup noted, “2Q13 results were ahead of our and the Street's expectations as the impact of the late quarter close of the PMTI deal was more pronounced than expected. Underlying trends remain healthy and we continue to expect a sizable jump in EPS in 2014 when the combined SG&A is leveraged.”
Cynosure closed on Wednesday at $28.48.
Latest Ratings for CYNO
|Nov 2016||Aegis Capital||Initiates Coverage On||Buy|
|Jan 2016||Stifel Nicolaus||Maintains||Buy|
|Sep 2015||Stifel Nicolaus||Upgrades||Hold||Buy|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.